Table 3 Risk of cardio-cerebrovascular disease according to multivitamin use.

From: Multivitamin supplementation and its impact in metabolic dysfunction-associated steatotic liver disease

Multivitamin

Number of patients

Number of events

Number of events /

100 patient-years

HR (95% CI)

P value

Entire cohort

     

 Non-user

389,080

63,589

1.202

Reference

 

 User

13,396

1,735

0.920

0.74 (0.71, 0.78)

< 0.001

No SLD

 

 Non-user

159,695

15,288

0.674

Reference

 

 User

6,123

557

0.629

0.89 (0.82, 0.97)

0.008

MASLD

 

 Non-user

229,385

48,301

1.598

Reference

 

 User

7,273

1,178

1.176

0.72 (0.68, 0.76)

< 0.001

  1. HR, hazard ratio; CI, confidence interval; SLD, steatotic liver disease; MASLD, metabolic dysfunction-associated steatotic liver disease.
Back to article page